Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
3.5K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

1000
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1000
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

300
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
300

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of systemic lupus erythematosus: new therapeutic options.

Revista clinica espanola·2023
Same author

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.

Medicina (Kaunas, Lithuania)·2023
Same author

Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

Journal of translational medicine·2022
Same author

Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial.

HIV medicine·2021
Same author

Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.

Lupus·2019
Same author

Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.

Lupus·2018
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
Same journal

Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators.

Lupus·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
09:10

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Published on: February 22, 2020

9.4K

SLE: the changing prognosis.

A Ugarte1, G Ruiz-Irastorza2

  • 1Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.

Lupus
|June 17, 2016
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) prognosis improved, but damage from high-dose glucocorticoids is rising. Optimizing hydroxychloroquine use, glucocorticoid management, and cardiovascular care can enhance long-term outcomes for SLE patients.

Keywords:
Antiphospholipid syndromenephritissystemic lupus erythematosusthrombosis

More Related Videos

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
08:08

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy

Published on: October 16, 2013

11.0K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Related Experiment Videos

Last Updated: Mar 19, 2026

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
09:10

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Published on: February 22, 2020

9.4K
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
08:08

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy

Published on: October 16, 2013

11.0K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Area of Science:

  • Rheumatology and Immunology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) prognosis significantly improved in the 20th century due to better understanding and therapies.
  • A plateau in prognosis has been reached, with increasing damage accrual, particularly from high-dose glucocorticoids.
  • Cardiovascular disease and infections remain leading causes of mortality in SLE patients.

Purpose of the Study:

  • To analyze the current trends in SLE prognosis.
  • To identify factors contributing to morbidity and mortality.
  • To propose strategies for improving long-term outcomes in SLE.

Main Methods:

  • Review of historical and current data on SLE outcomes.
  • Analysis of treatment-related adverse effects, especially from glucocorticoids.
  • Evaluation of the impact of specific therapies like hydroxychloroquine.

Main Results:

  • While active disease outcomes have improved, long-term damage is increasing, often linked to high-dose glucocorticoid use.
  • High-dose glucocorticoids contribute to increased morbidity and potentially worse long-term prognosis.
  • Cardiovascular disease and infections are major causes of death, potentially influenced by glucocorticoid therapy.

Conclusions:

  • Universal hydroxychloroquine use is recommended.
  • Rational prescription of glucocorticoids is crucial for minimizing damage.
  • Preventive strategies for cardiovascular disease are essential for improving SLE patient prognosis.